Mission Produce, Inc.

  Founded in 1983, we are a world leader in sourcing, producing and distributing fresh avocados, serving retail, wholesale and foodservice customers in over 25 countries. Our operations consist of four packing facilities in the United States, Mexico and Peru, 11 distribution and ripening centers across the U.S., Canada, China and the Netherlands, as well […]

September 4, 2020 Read More

Falcon Capital Acquisition

  (This is a newly organized blank check company. Its CEO, Alan G. Mnuchin, is the brother of U.S. Treasury Secretary Steven Mnuchin.) While we may pursue an initial business combination opportunity in any industry or sector, we intend to focus on businesses in the media, digital media/consumer technology, interactive entertainment and related industries which […]

September 3, 2020 Read More

Blue Water Acquisition Corp.

We intend to focus our search for a target business in the healthcare or healthcare-related industries in the United States and Europe. In particular, we intend to prioritize companies in the life sciences and pharmaceutical services sectors, where our management team has extensive experience.

Read More

Taysha Gene Therapies, Inc.

We are a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. (AAV stands for adeno-associated virus.) Our most advanced product candidates include TSHA-101, which is being developed to treat genetic disorders that include Tay-Sachs disease, […]

September 2, 2020 Read More

Bluescape Opportunities Acquisition Corp.

We have not selected any business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. Our sponsor is Bluescape Sponsor LLC, an affiliate of Bluescape Energy Partners, a private investment firm based in Dallas, Texas, with a value-oriented focus. We […]

Read More

Laird Superfood, Inc.

  Laird Superfood is an emerging consumer products platform focused on manufacturing and marketing highly differentiated plant-based and functional foods. The Laird Superfood brand is increasingly recognized and trusted by a growing number of consumers. The core pillars of the Laird Superfood platform are currently Superfood Creamer coffee creamers, Hydrate hydration products and beverage-enhancing supplements, […]

August 31, 2020 Read More

Oaktree Acquisition Corp. II

We are a blank check company newly incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.  While we may pursue an […]

Read More

Hygo Energy Transition Ltd.

We provide integrated downstream LNG solutions to underserved markets by delivering low cost, environmentally sound energy alternatives to consumers around the world. Our business includes (i) our network of existing and development stage marine LNG import terminals, (ii) our ownership of interests in existing and development stage large-scale power plants backed by high quality offtakers, and (iii) the […]

Read More

Reinvent Technology Partners

Reid Hoffman, Mark Pincus, and Michael Thompson have established Reinvent Technology Partners, a newly formed blank check company, to partner with a technology business to innovate and achieve entrepreneurship at scale by leveraging their operating expertise as founders of iconic technology companies, their experience building companies as advisors and board members, and the capital raised […]

Read More

COMPASS Pathways plc

We are a mental health care company pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support, to help people with treatment-resistant depression. We have developed a proprietary high-purity polymorphic crystalline formulation of psilocybin, COMP360. In 2019, we completed a Phase I clinical trial administering […]

August 28, 2020 Read More